Venture Capital

With a $5.7M seed round, Flourish Care is scaling its tech platform to integrate doula support into mainstream healthcare, tackling the maternal health crisis.

Tempest Therapeutics raises up to $6M in a critical financing deal to advance its CAR-T pipeline, balancing promising clinical data with financial pressures.

The bioconjugate CRDMO reports record profits and a $1.49B backlog, fueled by tech innovation, strategic acquisitions, and global expansion.

A key preclinical success in a $570M partnership advances a novel therapy designed to reset the immune system for patients with lupus, MS, and arthritis.

A landmark land lease agreement paves the way for Taiwan's first onshore wave energy station, a key test for the island's renewable goals and a major win for Eco Wave Power.

Lifecore Biomedical secures its third major manufacturing deal in five months, signaling a strategic shift that could reshape the aesthetics supply chain.

Founder Dr. Bill Rivard moves to Chairman as veteran Tricia Brown takes the helm, signaling a new era for military healthcare staffing.

With the appointment of Ben Wright as CRO, Insight Assurance signals a major push for global growth, leveraging AI to tackle complex cybersecurity regulations.

Q2 Metals reports stunning 200+ meter lithium intercepts in Quebec but delays its resource estimate, betting that bigger is better for the EV market.

With major expansions in the US and Europe, Cambrex aims to lead the high-stakes race for specialized API production, targeting next-generation therapies.

UK biotech Amphista to showcase its innovative Targeted Glue™ platform at AACR, revealing new data for AML, lung cancer, and mesothelioma therapies.

A new R&D center in Singapore is using AI to build atomic-scale machines, tackling the critical hardware bottleneck for the next generation of AI.

A top university and a global clinical research firm unite to slash drug development timelines, aiming to bring innovative therapies to patients faster.

Use your favorite Xbox or Switch Pro controller on the PS5 with no compromises. Brook's new adapter promises zero lag and full features. We dive in.

An ambitious redevelopment at Tower 49, led by Kato International and Industrious, is creating a new blueprint for the future of work in Manhattan.

DMZ's summit channels $210,000 to women-led startups, signaling a strategic push into Canada’s critical AI, defence, and cybersecurity sectors.

A breakthrough test achieves unprecedented power for E-band wireless, overcoming key hurdles to connect remote areas and lay the groundwork for 6G.

Apple iSports hires innovation guru Ian Wilding to guide its Nasdaq ambitions, a move underscored by a corrective press release signaling growing pains.

Trian Fund Management publicly rejects Victory Capital’s higher offer for Janus Henderson, citing 'significant value destruction' and setting up a showdown.

With a history of billion-dollar deals, Mark Altmeyer takes the helm at ReproNovo, aiming to commercialize its promising fertility and women's health pipeline.